2-PMAP   Click here for help

GtoPdb Ligand ID: 7530

Synonyms: AGN-PC-0031SD | ARN-2966
Compound class: Synthetic organic
Comment: 2-PMAP is an investigational compound for Alzheimer's disease (AD). A recent study has demonstrated that this compound crosses the blood-brain barrier and reduces levels of full-length amyloid precursor protein (APP) and amyloid beta (Aβ) deposition in the brains of AD model mice without causing significant toxicity [1]. This is accompanied by reduced Aβ pathology and rescue of memory deficit in AD model mice via an inhibitory effect on mRNA translation. This compound may exist as a tautomer with PubChem CID 68604369.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 45.15
Molecular weight 200.09
XLogP 2.24
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Oc1ccccc1NCc1ccccn1
Isomeric SMILES Oc1ccccc1NCc1ccccn1
InChI InChI=1S/C12H12N2O/c15-12-7-2-1-6-11(12)14-9-10-5-3-4-8-13-10/h1-8,14-15H,9H2
InChI Key GXJRVWZNMZGWAQ-UHFFFAOYSA-N
No information available.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
In vitro, 2-PMAP is reported to reduce the steady-state level of APP, thereby limiting cleavage to Aβ [1], but does not affect APP transcription. Further protein translation analysis, reported in this same article, demonstrates that 2-PMAP acts as a selective APP post-transcriptional modulator, although its precise molecular mechanism of action is unclear.